MAP2K7 and hepatocellular carcinoma: DGKα expression is involved in hepatocellular carcinoma progression and is a positive regulator of the proliferative activity of hepatocellular carcinoma through the Ras/Raf/MEK/ERK pathway (Takeishi et al., 2012).